Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Prevention”

1,511 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,511 results

Large-scale testing (Phase 3)Study completedNCT00195754
What this trial is testing

A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER in Subjects Who Either Completed or Prematurely Discontinued Due to Ineffectiveness From Study M02-488.

Who this might be right for
Migraines
Abbott 114
Not applicableWithdrawnNCT01659346
What this trial is testing

Non-selective Beta Blockers Versus EVL for Primary Prophylaxis of Esophageal Variceal Bleeding in Patients With Hepatocellular Carcinoma With Portal Vein Tumour Thrombosis.

Who this might be right for
Hepatocellular Carcinoma With Portal Vein Thrombosis
Institute of Liver and Biliary Sciences, India
Post-approval studies (Phase 4)Study completedNCT01300546
What this trial is testing

Treximet Trademark (TM) in the Prevention and Modification of Disease Progression in Migraine

Who this might be right for
Migraine
Cady, Roger, M.D. 40
Post-approval studies (Phase 4)UnknownNCT02123056
What this trial is testing

Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects

Who this might be right for
Vasovagal Syncope
University of Calgary 52
Large-scale testing (Phase 3)UnknownNCT06576154
What this trial is testing

The Role of Antibiotic Prophylaxis in Lowering Wound Infection Rates Post-Open Repair of Primary Elective Groin Hernias in High-Risk Patients

Who this might be right for
Antibiotic ProphylaxisWound InfectionGroin Hernia
University of Aleppo 200
Not applicableNot Yet RecruitingNCT06728345
What this trial is testing

The Real-world Study of Rimegepant Treatment in Female Migraine Patients of China

Who this might be right for
MigraineMigraine Prophylaxis
The First Affiliated Hospital of Soochow University 300
Not applicableNot Yet RecruitingNCT06730737
What this trial is testing

Lifewise Preventive Video Education in Primary Care

Who this might be right for
Prevention Harmful EffectsHealth MaintenancePreventive Health Care+1 more
Trinity Health-Livonia 350
Large-scale testing (Phase 3)Study completedNCT02003703
What this trial is testing

Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV .

Who this might be right for
Hepatitis BHIV
Universidad de Valparaiso 107
Large-scale testing (Phase 3)Study completedNCT05861427
What this trial is testing

Study of Oral Atogepant Tablets to Assess Change in Disease Activity in Adult Japanese Participants With Episodic Migraine

Who this might be right for
Migraine
AbbVie 524
Not applicableStudy completedNCT02026102
What this trial is testing

A Pilot Trial of Patient Decision Aids for Implantable Cardioverter-Defibrillators (ICDs)

Who this might be right for
Systolic Heart FailureSudden Cardiac Death
University of Colorado, Denver 15
Not applicableUnknownNCT02028195
What this trial is testing

Effectiveness and Cost-effectiveness of the Check Your Health Preventive Programme

Who this might be right for
Health PromotionCardiovascular DiseasePhysical Inactivity+2 more
University of Aarhus 11,000
Not applicableStudy completedNCT01596595
What this trial is testing

Longitudinal Surveillance Study of the 4-SITE Lead/Header System

Who this might be right for
Primary Prevention of Sudden Cardiac ArrestSecondary Prevention of Sudden Cardiac Arrest
Boston Scientific Corporation 1,820
Not applicableStudy completedNCT06194331
What this trial is testing

Optimizing Suicide Prevention Strategies for Pediatric Primary Care

Who this might be right for
Suicidal IdeationSuicidal and Self-injurious BehaviorDepression
University of Pittsburgh 30
Not applicableLooking for participantsNCT06409832
What this trial is testing

RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment

Who this might be right for
MigraineMigraine With AuraMigraine Without Aura
University of Florence 100
Not applicableStudy completedNCT03316911
What this trial is testing

A Pilot Study Testing a Life Skills Application to Address Interpersonal Relationships in College

Who this might be right for
Sexual ViolencePrimary Prevention
University of Michigan 261
Not applicableUnknownNCT03190044
What this trial is testing

Magnesium, Partenium, Andrographis, Co-enzyme Q10 and Riboflavin (PACR) in Migraine Prophylaxis

Who this might be right for
Migraine Disorders
University of Roma La Sapienza 82
Not applicableStudy completedNCT03382353
What this trial is testing

EMuNI Project: Multiple Nonpharmacological Interventions

Who this might be right for
Lifestyle Risk Reduction
IRCCS Centro San Giovanni di Dio Fatebenefratelli 120
Large-scale testing (Phase 3)Study completedNCT00944034
What this trial is testing

Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered as Booster Dose at 12, 18 or 24 Months of Age in Toddlers (12-24 Months) Primed With a Three-Dose Immunization Series as Infants in Study V72P12

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 1,588
Testing effectiveness (Phase 2)Looking for participantsNCT06485336
What this trial is testing

Prophylactic Treatment With Atorvastatin for Chronic Migraine (ChronicStatinMig)

Who this might be right for
Chronic Migraine
St. Olavs Hospital 300
Testing effectiveness (Phase 2)Ended earlyNCT00720629
What this trial is testing

Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Graft Versus Host Disease
H. Lee Moffitt Cancer Center and Research Institute 8
Next Page